Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index.
McDonagh CF, Kim KM, Turcott E, Brown LL, Westendorf L, Feist T, Sussman D, Stone I, Anderson M, Miyamoto J, Lyon R, Alley SC, Gerber HP, Carter PJ.
McDonagh CF, et al. Among authors: turcott e.
Mol Cancer Ther. 2008 Sep;7(9):2913-23. doi: 10.1158/1535-7163.MCT-08-0295.
Mol Cancer Ther. 2008.
PMID: 18790772
Free article.